|
|
|
|
 |
News and Press Releases |
 |
Carlyle and Brighton Park agree to invest US$200 million in Indegene
The Carlyle Group (NASDAQ: CG), Brighton Park Capital and Indegene, the Bangalore-headquartered enterprise healthtech solutions provider, today announced that Carlyle and Brighton Park Capital will acquire minority stakes in the company for US$200 million. The transaction, which is subject to customary regulatory approvals, consists of a secondary sale from existing shareholders of Indegene and a primary investment into the company.
More info >> |
|
 |
White Papers |
 |
|
|